Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects (original) (raw)
- Biotechnical Methods Section BTS
- Published: 08 December 1998
Biotechnical Methods Section (BTS)
Leukemia volume 12, pages 2029–2033 (1998)Cite this article
- 1340 Accesses
- 80 Citations
- 3 Altmetric
- Metrics details
Abstract
While it is known that mice with genetic immune defects are useful for establishing durable engraftment of human tumor xenografts, the relative role of components of host innate and adoptive immunity in engraftment has not been determined. We directly compared the ability of four strains of genetically immunodeficient mice (NOD/SCID, SCID, Nude and Rag-1-deficient) to successfully engraft and support the human cell lines Daudi, Raji, Namalwa and Molt-4 as subcutaneous tumors. We additionally examined the effect of further immunosuppression of the mice by whole body irradiation at a dose of 600 cGy for Nude and Rag-1 and 300 cGy for SCID mice and by administration of anti-natural killer (asialo-GM1) antibody on tumor growth. Mice with each of the defects supported xenografts to varying degrees. We found differences in growth characteristics in the cell lines tested, with Namalwa consistently producing the largest tumors. With all cell lines studied, optimal growth was achieved using NOD/SCID mice. Overall, tumor growth was somewhat enhanced by pretreatment with radiation with little additional benefit from the addition of anti-asialo-GM1 antibody. The importance of multiple components of the innate and adoptive immune system in xenotransplantation were best demonstrated when results in untreated NOD/SCID mice were compared to SCID, nude and RAG-1-deficient mice. The NOD/SCID mouse with or without additional immunosuppression provides the optimal model for the study of the biology and treatment of human leukemias and lymphomas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Departments of Pediatrics and Laboratory Medicine/Pathology, Cancer Center, University of Minnesota, Minneapolis, MN, USA
WA Hudson, Q Li & JH Kersey - Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA
C Le
Authors
- WA Hudson
You can also search for this author inPubMed Google Scholar - Q Li
You can also search for this author inPubMed Google Scholar - C Le
You can also search for this author inPubMed Google Scholar - JH Kersey
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Hudson, W., Li, Q., Le, C. et al. Xenotransplantation of human lymphoid malignancies is optimized in mice with multiple immunologic defects.Leukemia 12, 2029–2033 (1998). https://doi.org/10.1038/sj.leu.2401236
- Received: 02 October 1997
- Accepted: 09 September 1998
- Published: 08 December 1998
- Issue Date: 01 December 1998
- DOI: https://doi.org/10.1038/sj.leu.2401236